Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | INMT | O95050 | 4/20 | 1.00 |
| ▸ | USP2 | O75604 | 2/20 | 1.00 |
| ▸ | ACHE | P22303 | 6/20 | 0.38 |
| ▸ | NOS3 | P29474 | 4/20 | 0.36 |
| ▸ | NOS1 | P29475 | 4/20 | 0.36 |
| ▸ | NOS2 | P35228 | 4/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10601682 | 1.00 | INMT (1.00) | INMTUSP2ACHENOS3NOS1 | |
| SCHEMBL16583523 | 1.00 | INMT (1.00) | INMTUSP2ACHENOS3NOS1 | |
| SCHEMBL2401189 | 1.00 | INMT (1.00) | INMTUSP2ACHENOS3NOS1 | |
| SCHEMBL6853620 | 1.00 | INMT (1.00) | INMTUSP2ACHENOS3NOS1 | |
| SCHEMBL2734323 | 1.00 | INMT (1.00) | INMTUSP2ACHENOS3NOS1 | |
| SCHEMBL3047 | 1.00 | INMT (1.00) | INMTUSP2ACHENOS3NOS1 | |
| Iodide SCHEMBL23365018 | 0.98 | INMT (0.95) | INMTUSP2ACHENOS3NOS1 | |
| Ammonia Solution, Strong SCHEMBL6834929 | 0.98 | INMT (0.95) | INMTUSP2ACHENOS3NOS1 | |
| Bromide SCHEMBL8469764 | 0.98 | INMT (0.95) | INMTUSP2ACHENOS3NOS1 | |
| SCHEMBL2544511 | 0.98 | INMT (0.95) | INMTUSP2ACHENOS3NOS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2980180-A1 | PHOTOBASE GENERATOR | San-Apro Ltd. (JP) | 2016-02-03 | — | — | EP | disclosed |
| US-20160009737-A1 | PHOTOBASE GENERATOR | SAN-APRO LTD. (JP) | 2016-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160009737-A1 | PHOTOBASE GENERATOR | PSMC6, ARCN1, CRY1 | INMT 2856/4885USP2 3568/4885ACHE 3281/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.